Quintiles' Stake In NitroMed Is First Co-Investment With Care Capital
Executive Summary
Quintiles' stake in nitric oxide-based medicines company NitroMed represents one of two initial co-investments under a strategic alliance with venture capital firm Care Capital.
You may also be interested in...
Quintiles Expects Expanded Services Contribution To CSO To Be 50% By 2005
Quintiles' expanded non-traditional services will account for roughly 50% of the company's contract sales revenues by the end of 2005 following a reorganization effort, Quintiles predicts.
Quintiles Expects Expanded Services Contribution To CSO To Be 50% By 2005
Quintiles' expanded non-traditional services will account for roughly 50% of the company's contract sales revenues by the end of 2005 following a reorganization effort, Quintiles predicts.
Scios/Quintiles Natrecor Deal Includes Funding, Sales Support
Scios will provide incentives to Innovex for getting its acute decompensated congestive heart failure treatment Natrecor approved for hospital formularies as part of a marketing agreement with Quintiles.